Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001916595 | SCV002190040 | likely benign | not provided | 2024-02-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001916595 | SCV003805772 | uncertain significance | not provided | 2022-08-19 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Neuberg Centre For Genomic Medicine, |
RCV004762255 | SCV005373571 | uncertain significance | Febrile seizures, familial, 4 | 2023-06-02 | criteria provided, single submitter | clinical testing | The missense variant c.12896G>A (p.Arg4299Gln) in ADGRV1 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant is reported with the allele frequency (0.0008%) in the gnomAD Exomes. This variant has been reported to the ClinVar database as Uncertain Significance. However, no details are available for independent assessment. The amino acid Arginine at position 4299 is changed to a Glutamine changing protein sequence and it might alter its composition and physico- chemical properties. Computational evidence (Polyphen, SIFT and MutationTaster) predicts conflicting evidence on protein structure and function for this variant. The amino acid change p.Arg4299Gln in ADGRV1 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Uncertain Significance. |